Warning Letter Close-Outs – February 2016
This article was originally published in The Gray Sheet
Two FDA close-out letters were released in February.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.